# Comparing Three Different Doses of Intrathecal Ketamine

> **NCT05074823** · PHASE4 · COMPLETED · sponsor: **Assiut University** · enrollment: 105 (actual)

## Conditions studied

- Ketamine Causing Adverse Effects in Therapeutic Use

## Interventions

- **DRUG:** Ketamine 0.1 mg
- **DRUG:** Ketamine 0.2 mg
- **DRUG:** Ketamine 0.3 mg

## Key facts

- **NCT ID:** NCT05074823
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-26
- **Primary completion:** 2023-07-10
- **Final completion:** 2023-07-11
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2023-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05074823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05074823, "Comparing Three Different Doses of Intrathecal Ketamine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05074823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*